Opendata, web and dolomites

Mofina

Mobile Filovirus Nucleic Acid Test – Sofia ref.: 115848

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Mofina project word cloud

Explore the words cloud of the Mofina project. It provides you a very rough idea of what is the project "Mofina" about.

material    april    fast    nucleic    advantage    bnitm    time    designed    2015    integration    screening    kit    starts    rt    platform    species    deg    proven    acid    min    technologies    mark    human    acute    assay    manufactured    simplify    until    instrument    cartridge    utilize    risk    prototypic    marburgvirus    diagnostics    pan    safe    rapid    45    simultaneously    pcr    logistics    filovirus    molecular    commercial    system    workflow    inmi    ce    additional    combining    cartridges    hiv    capillary    detect    disposable    proposing    filo    reg    detection    samples    trade    expanded    poc    validation    central    instrumentation    nat    operator    realstar    genera    infection    20    sites    blood    rna    sensitive    infrastructure    format    ivd    complete    preparation    care    point    purpose    verification    ready    stand    ebola    mobile    storage    alone    safely    laboratory    alere    reducing    march    virus    venous    sampling    altona   

Project "Mofina" data sheet

The following table provides information about the project.

Coordinator
Department of Health 

Organization address
address: Quarry House, Quarry Hill
city: Leeds
postcode: LS2 7UE
website: www.dh.gov.uk

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Project website https://www.imi.europa.eu/projects-results/project-factsheets/mofina
 Total cost 4˙398˙252 €
 EC max contribution 1˙162˙622 € (26%)
 Programme 1. H2020-EU.3.1.7. (Innovative Medicines Initiative 2 (IMI2))
 Code Call H2020-JTI-IMI2-2014-02-single-stage
 Funding Scheme IMI2-RIA
 Starting year 2015
 Duration (year-month-day) from 2015-02-01   to  2017-04-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    Department of Health UK (Leeds) coordinator 332˙460.00
2    ALTONA DIAGNOSTICS GMBH DE (HAMBURG) participant 394˙178.00
3    BERNHARD-NOCHT-INSTITUT FUER TROPENMEDIZIN DE (HAMBURG) participant 217˙992.00
4    ISTITUTO NAZIONALE PER LE MALATTIE INFETTIVE LAZZARO SPALLANZANI-ISTITUTO DI RICOVERO E CURA A CARATTERE SCIENTIFICO IT (ROMA) participant 217˙992.00
5    ALERE TECHNOLOGIES GMBH DE (JENA) participant 0.00
6    FOUNDATION FOR INNOVATIVE NEW DIAGNOSTICS CH (GENEVE) participant 0.00

Map

 Project objective

We are proposing to develop a molecular assay for the safe, rapid, specific and sensitive detection of Ebola Virus Infection in capillary (or venous) blood samples combining ALTONA’s Pan-filo screening IVD test with the existing Alere™ q point of care molecular diagnostics platform. The purpose of this project is to utilize existing and proven PCR assay(s) designed for laboratory use and to take advantage of the Alere™ q point of care molecular instrument and cartridge design to simplify Ebola testing so that molecular testing can be expanded to sites beyond which high end laboratory infrastructure is not available while simultaneously greatly reducing infection risk for the test operator. The project aims for the fast development of a point of care Nucleic Acid Test (POC-NAT) system for filovirus specific RNA, from human sample material, especially from blood samples. The POC-NAT system will have the following features: 1. Field proven stand alone, mobile and easy to use instrumentation 2. ready to use cartridge, safely disposable nucleic acid test format with integrated sample preparation 3. assay for specific detection of RNA of all known species from the virus genera Ebola- and Marburgvirus . 4. process duration from sampling to result less than 45 min 5. no additional equipment and no logistics and storage at -20°C needed The POC-NAT is based on two already existing technologies: The instrument platform “Alere™q complete” developed and manufactured by Alere , an instrument for POC diagnostics recently used p.e. for Alere´s HIV-1/2 Detect cartridges, and altona Diagnostics´ RealStar® Filovirus RT-PCR kit 1.0, a commercial central laboratory real-time PCR test. The project partner aim for having the integration of platform and assay as a prototypic system completed until end of March 2015. The verification and validation of the workflow starts April 2015 at altona Diagnostics, BNITM and INMI. The aim of this project phase is to finally CE IVD mark the test system

 Publications

year authors and title journal last update
List of publications.
2015 Chris A Whitehouse, Sina Bavari, Mark D Perkins
United States FDA’s emergency use authorization of Ebola virus diagnostics: current impact and lessons for the future
published pages: 1231-1235, ISSN: 1473-7159, DOI: 10.1586/14737159.2015.1077117
Expert Review of Molecular Diagnostics 15/10 2019-07-24
2015 Mark D Perkins, Mark Kessel
What Ebola tells us about outbreak diagnostic readiness
published pages: 464-469, ISSN: 1087-0156, DOI: 10.1038/nbt.3215
Nature Biotechnology 33/5 2019-07-24

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MOFINA" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MOFINA" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.7.)

AB-DiRecT (2019)

Antibiotic Distribution and Recovery in Tissue

Read More  

VITAL (2019)

Vaccines and Infectious Diseases in the Ageing PopuLation

Read More  

WEB-RADR 2 (2018)

WEB-RADR 2

Read More